Compass Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ORBIMED ADVISORS LLC | 05/15/2025 | 22.36 M | $42.49 M | 0.00% | 16.25% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 11.05 M | $21.00 M | 87.33% | 8.03% |
BLACKSTONE INC. | 05/15/2025 | 10.03 M | $19.05 M | 0.00% | 7.29% |
BIOIMPACT CAPITAL LLC | 05/15/2025 | 8.44 M | $16.04 M | -1.46% | 6.14% |
05/15/2025 | 7.79 M | $14.80 M | 0.00% | 5.66% | |
BLACKROCK, INC. | 05/02/2025 | 7.11 M | $13.51 M | 3.22% | 5.17% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 4.96 M | $9.43 B | -14.13% | 3.61% |
VANGUARD GROUP INC | 05/09/2025 | 4.84 M | $9.19 M | 2.54% | 3.52% |
FMR LLC | 05/12/2025 | 4.13 M | $7.86 M | -0.05% | 3.00% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 3.98 M | $7.55 M | -33.69% | 2.89% |
VIVO CAPITAL, LLC | 05/12/2025 | 3.56 M | $6.76 M | 0.00% | 2.58% |
BLUE OWL CAPITAL HOLDINGS LP | 05/15/2025 | 2.95 M | $5.61 M | 0.00% | 2.15% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.36 M | $4.49 M | 1.32% | 1.72% |
JPMORGAN CHASE & CO | 05/12/2025 | 2.19 M | $4.15 M | 702.52% | 1.59% |
STATE STREET CORP | 05/15/2025 | 1.95 M | $3.70 M | 2.45% | 1.42% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 1.33 M | $2.53 M | 100.00% | 0.97% |
SG AMERICAS SECURITIES, LLC | 04/15/2025 | 940.78 K | $1.79 M | 138.16% | 0.68% |
SILVERARC CAPITAL MANAGEMENT, LLC | 05/14/2025 | 874.87 K | $1.66 M | 100.00% | 0.64% |
MORGAN STANLEY | 05/15/2025 | 839.18 K | $1.59 M | 121.68% | 0.61% |
NORTHERN TRUST CORP | 05/13/2025 | 803.14 K | $1.53 M | 0.24% | 0.58% |
MACQUARIE GROUP LTD | 05/15/2025 | 681.54 K | $1.30 K | 100.00% | 0.50% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 662.20 K | $1.26 M | 100.00% | 0.48% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 561.20 K | $1.07 M | 100.00% | 0.41% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 547.50 K | $1.04 M | -64.85% | 0.40% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 545.09 K | $1.04 M | 1,509.97% | 0.40% |
MONASHEE INVESTMENT MANAGEMENT LLC | 05/14/2025 | 448.16 K | $851.51 K | 0.00% | 0.33% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 383.50 K | $728.66 K | 239.32% | 0.28% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 332.10 K | $630.99 K | 100.00% | 0.24% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 321.50 K | $610.85 K | 15.40% | 0.23% |
05/12/2025 | 304.50 K | $578.56 K | 100.00% | 0.22% | |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 297.88 K | $565.97 K | 4.08% | 0.22% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 253.40 K | $481.46 K | 100.00% | 0.18% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 243.57 K | $462.77 K | 2.35% | 0.18% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 233.52 K | $443.69 K | -40.19% | 0.17% |
PROPEL BIO MANAGEMENT, LLC | 05/15/2025 | 228.32 K | $433.80 K | 100.00% | 0.17% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 222.51 K | $422.76 K | 100.00% | 0.16% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 212.30 K | $403.37 K | 100.00% | 0.15% |
05/15/2025 | 200.00 K | $380.00 K | 100.00% | 0.15% | |
HAP TRADING, LLC | 05/14/2025 | 199.80 K | $89.74 K | 100.00% | 0.15% |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 170.61 K | $324.15 K | -0.50% | 0.12% |
CITADEL ADVISORS LLC | 05/15/2025 | 169.60 K | $322.24 K | 100.00% | 0.12% |
CANTOR FITZGERALD, L. P. | 05/15/2025 | 150.00 K | $285.00 K | 50.00% | 0.11% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 138.80 K | $264.02 K | 1,148.56% | 0.10% |
HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 134.00 K | $254.60 K | 100.00% | 0.10% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 131.50 K | $249.84 K | 140.77% | 0.10% |
CITIGROUP INC | 05/12/2025 | 131.24 K | $249.35 K | 66.96% | 0.10% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 130.81 K | $248.53 K | 100.00% | 0.10% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 130.80 K | $248.52 K | 100.00% | 0.10% |
RHUMBLINE ADVISERS | 05/29/2025 | 120.03 K | $228.05 K | -7.04% | 0.09% |
SIMPLIFY ASSET MANAGEMENT INC. | 05/13/2025 | 120.00 K | $228.00 K | 100.00% | 0.09% |
Compass Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 116 institutional investors and hedge funds held shares of Compass Therapeutics, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 22.36 M
TANG CAPITAL MANAGEMENT LLC: 11.05 M
Blackstone Inc.: 10.03 M
BioImpact Capital LLC: 8.44 M
BlackRock, Inc.: 7.11 M
Rock Springs Capital Management LP: 4.96 M
79.07% of Compass Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 111.66 M shares in the last 24 months. This purchase volume represents approximately $234.48 M in transactions.